|
US stocks drift in mixed trading as oil prices keep spurting higher AP NewsStock market today: Dow, S&P 500, Nasdaq drop as chip stocks sink on OpenAI report, oil rises Yahoo FinanceCNBC Daily Open: Investors look past warning signs to send stock markets soaring CNBCWar and uncertainty in Iran fail to cool a red-hot U.S. stock market
|
|
S&P 500 is little changed as oil rises, traders brace for Fed decision and Big Tech earnings: Live updates CNBC‘All-In Wednesday' to Test Stock Market Where ‘Everyone's Long' Bloomberg.comFed Meeting Live: Markets Await Powell's Last Interest-Rate Decision as Chair WSJStock Market Today: Dow falls over 300 points, S&P 500 edges lower, while Nasdaq wavers ahead of Fed decision and tech earnings MarketWatch
|
|
The struggles of the nascent private-capital market, weighed down by lending to software companies whose businesses are under attack from artificial intelligence, has captured the eye of the market and the news media.
|
|
Meta is paying top executives to hit a $9.5 trillion valuation—and no one's ever done it before FortuneMeta shares look 'iffy' into earnings. How to trade it CNBCHow Much Is Meta Stock Expected to Move After Earnings? InvestopediaCan Meta make money on AI beyond consumer ads? That's a big question going into earnings. MarketWatch
|
|
Astorg has agreed a roughly $1bn buyout of Thermo Fisher Scientific's microbiology business. The arm, which provides antimicrobial susceptibility testing and culture media solutions for clinical, pharmaceutical and food safety testing, generated $645m in revenue last year. Thermo Fisher expects the deal to close in the second half of 2026. Astorg said the market was […]
The post Deal Roundup: Astorg agrees $1bn buyout of Thermo Fisher microbiology unit, O2 Investment backs Steffl Drilling & Pump appeared first on AltAssets Private Equity News.
|
|
